Exploring the Cancer-Associated Role of PITRM1: A Pan-Cancer Bioinformatics Analysis
Amaara Subramaniam
31/10/2026
PITRM1 is a mitochondrial protein that plays a role in protein quality control and normal mitochondrial function. Previous studies have shown that PITRM1 plays a role in mitochondrial homeostasis, neurodegeneration, and a number of other established functions, but recent evidence has emerged for a role in cancer biology. By leveraging publicly available cancer genomics datasets, the genomic alterations, expression patterns, mutation distribution, and survival associations of PITRM1 in cancer were examined. A pan-cancer analysis was performed on 12 studies, representing 156,010 samples and 148,790 patients, followed by brain-, lung-, and thyroid-focused analyses. The frequency of PITRM1 alteration differed by cancer type and included missense mutations, deep deletions, and amplifications. The pan-cancer survival analysis did not reveal any significant difference in overall survival with PITRM1 alteration status (p=0.662). In contrast, PITRM1 alterations were significantly associated with poorer survival in brain cancer (p = 1.462 × 10⁻⁴; HR = 2.641) and thyroid cancer (p = 7.119 × 10⁻⁴; HR = 2.150). There was no significant association with survival in lung cancer (p = 0.435). The different types of PITRM1 mutations were found throughout the protein domains by mutation analysis. These results indicate that the cancer association of PITRM1 could be dependent on tumor type and biological context. Additional clinical and experimental research is needed to evaluate the potential prognostic or functional role of PITRM1 in particular cancers.
